[Mode of action of megacin Cx on Bacillus megaterium KM].
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000327:Adsorption; D001410:Bacillus megaterium / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D001426:Bacterial Proteins / Q000096:biosynthesis; D001430:Bacteriocins / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology*; D001435:Bacteriophages / Q000187:drug effects / Q000254:growth & development; D002473:Cell Wall / Q000187:drug effects; D003470:Culture Media; D004269:DNA, Bacterial / Q000096:biosynthesis; D003864:Depression, Chemical; D004790:Enzyme Induction / Q000187:drug effects; D005696:Galactosidases / Q000096:biosynthesis; D010101:Oxygen Consumption / Q000187:drug effects; D010758:Phosphorus / Q000378:metabolism; D011523:Protoplasts / Q000187:drug effects; D012329:RNA, Bacterial / Q000096:biosynthesis; D013696:Temperature; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D001426:Bacterial Proteins; D001430:Bacteriocins; D003470:Culture Media; D004269:DNA, Bacterial; D012329:RNA, Bacterial; D010758:Phosphorus; D000255:Adenosine Triphosphate; D005696:Galactosidases
Untersuchungen zur Wirkungsweise von Megacin Cx auf Bacillus megaterium KM.